Clal Insurance’s Albemarle ALB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-2,500
Closed -$585K 192
2021
Q4
$585K Sell
2,500
-1,500
-38% -$371K 0.01% 149
2021
Q3
$877K Sell
4,000
-2,500
-38% -$534K 0.01% 154
2021
Q2
$1.1M Sell
6,500
-500
-7% -$80.7K 0.01% 148
2021
Q1
$1.02M Sell
7,000
-2,000
-22% -$321K 0.01% 144
2020
Q4
$1.24M Hold
9,000
0.02% 103
2020
Q3
$804K Hold
9,000
0.01% 104
2020
Q2
$695K Sell
9,000
-1,000
-10% -$68K 0.01% 108
2020
Q1
$564K Buy
10,000
+8,357
+509% +$640K 0.01% 102
2019
Q4
$22.5K Sell
1,643
-18,357
-92% -$1.23M 0.02% 97
2019
Q3
$1.39M Hold
20,000
0.03% 87
2019
Q2
$1.41M Buy
20,000
+7,500
+60% +$554K 0.03% 79
2019
Q1
$1.02M Hold
12,500
0.03% 80
2018
Q4
$963K Hold
12,500
0.03% 74
2018
Q3
$1.25M Buy
12,500
+2,500
+25% +$242K 0.03% 65
2018
Q2
$943K Buy
+10,000
New +$960K 0.02% 61

Other funds holding ALB

Clal Insurance's ALB Position: Q1 2022 in Review

Clal Insurance sold out of Albemarle (ALB) in Q1 2022, closing a stake of 2,500 shares — an estimated $585K sold.

Clal Insurance first reported a position in ALB in Q2 2018 and held it in 15 quarters. The position peaked at $1.41M in Q2 2019. 857 funds tracked by Wall St. Rank hold ALB as of Q1 2022.

  • Clal Insurance reported no remaining Albemarle position as of Q1 2022 after selling out during the quarter.
  • Clal Insurance sold 2,500 Albemarle shares in Q1 2022, an estimated $585K.
  • Clal Insurance first reported a position in Albemarle in Q2 2018 and held it in 15 quarters.
  • Clal Insurance's Albemarle position peaked at $1.41M in Q2 2019.
  • 857 funds tracked by Wall St. Rank held Albemarle as of Q1 2022.

Based on Clal Insurance's 13F filing for Q1 2022, filed 12 May 2022.